Advances in the medical world have enabled professionals in this area to improve the capability of investigation and analysis of previously unknown health issues. In this conference, Benedict S. Maniscalco elaborates on a very important disease that affects almost every human being: atherosclerosis. He explains how this disease enters the body, and shares what its symptoms, main characteristics, and problem diagnosis are. He also describes how recently discovered calcifying nanoparticles have a great incidence in the evolution of atherosclerosis, as well as how it affects the cardiovascular system. Through many clinical studies, Maniscalco has been able to identify the source of this problem and the efficient ways to prevent its appearance and progression.
Nanobacterium Sanguineum Benedict S. Maniscalco
Auditorium at Hospital Universitario Esperanza Universidad Francisco Marroquín Guatemala, Janurary, 2010
A New Media - UFM production. Guatemala, May 2010 Camera: Adrián Méndez; digital editing: Alfredo Jop; index and synopsis: Sergio Bustamante; content reviser: Daphne Ortiz; publication: Carlos Petz/Daphne Ortiz
This work is licensed under a Creative Commons 3.0 License Este trabajo ha sido registrado con una licencia Creative Commons 3.0
Benedict S. Maniscalco
Benedict S. Maniscalco is a specialist in cardiovascular disease. He is chairman and CEO of Heartbeat International Foundation, Inc. and founder of St. Joseph’s Hospital Heart Institute in Tampa, Florida. He is a member of the American Medical Association, American Heart Association and fellow of the American College of Cardiology, American College of Physicians, and others. Dr. Maniscalco holds a MD from Duke University and a BS from University of Florida. He did his postgraduate training in internal medicine and cardiovascular disease at Emory University affiliated hospitals.